About Cerapedics
Cerapedics is a company based in Westminster (United States) founded in 2006. Cerapedics has raised $88.46 million across 10 funding rounds from investors including GE Capital, Orbimed and Oxford Finance. The company has 3 employees as of September 30, 2009. Cerapedics offers products and services including i-FACTOR P-15 Peptide Enhanced Bone Graft. Cerapedics operates in a competitive market with competitors including Kerecis, MiMedx Group, Ossio, EpiBone and Biocomposites, among others.
- Headquarter Westminster, United States
- Employees 3 as on 30 Sep, 2009
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cerapedics Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$88.46 M (USD)
in 10 rounds
-
Latest Funding Round
$22 M (USD), Series D
Jul 13, 2018
-
Investors
GE Capital
& 5 more
-
Employee Count
3
as on Sep 30, 2009
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cerapedics
Cerapedics offers a comprehensive portfolio of products and services, including i-FACTOR P-15 Peptide Enhanced Bone Graft.
FDA-approved product to accelerate bone healing in spine surgery.
People of Cerapedics
Unlock access to complete
Unlock access to complete
Funding Insights of Cerapedics
Cerapedics has successfully raised a total of $88.46M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $22 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cerapedics
Cerapedics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include GE Capital, Orbimed and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Cerapedics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cerapedics
Investment portfolio details for Cerapedics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cerapedics
Detailed financials for Cerapedics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cerapedics Comparisons
Peer comparison for Cerapedics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cerapedics
Cerapedics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kerecis, MiMedx Group, Ossio, EpiBone and Biocomposites, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| Locked | Locked | Locked |
Developer of stem cells to regrow damaged bones
|
|
| Locked | Locked | Locked |
Synthetic calcium composites are developed for bone repair and regeneration.
|
|
| Locked | Locked | Locked |
Implants for bone and cartilage regeneration are developed and provided.
|
Detailed competitors of Cerapedics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cerapedics
Complete news archive for Cerapedics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cerapedics
Cerapedics was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Cerapedics is headquartered in Westminster, United States.
Valeska Schroeder is the current CEO of Cerapedics.
Cerapedics is a funded company, having raised a total of $88.46M across 10 funding rounds to date.
As of Sep 30, 2009, the latest employee count at Cerapedics is 3.
Cerapedics was founded in 2006 and is headquartered in Westminster, United States. Operations focus on the orthobiologics sector, where proprietary synthetic small peptide technology is developed and commercialized. The iFACTOR Peptide Enhanced Bone Graft is offered as a biologic bone graft that incorporates a small peptide to support natural bone healing. An FDA IDE trial for iFACTOR was completed, meeting all four prespecified primary endpoints.
Cerapedics's top competitors include Kerecis, EpiBone and Theradaptive.
Cerapedics offers i-FACTOR P-15 Peptide Enhanced Bone Graft.
Cerapedics has 6 investors. Key investors include GE Capital, Orbimed, Oxford Finance, KCK MedTech, and MedImmune Ventures.